ObvioHealth Introduces ObvioGo
DCT platform to deliver stronger evidence of therapeutic efficacy and safety.
ObvioHealth announces the launch of ObvioGo, a decentralized clinical trial platform and mobile application.
ObvioGo's tech stack has been designed to capture and integrate multi-source data. The system incorporates digital instruments, real-world data, artificial intelligence, as well as integration with clinical systems via APIs and industry standard interfaces.
Read more about the new platform here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
